InvestorsHub Logo
Followers 19
Posts 1208
Boards Moderated 0
Alias Born 09/29/2016

Re: None

Thursday, 06/17/2021 5:59:14 PM

Thursday, June 17, 2021 5:59:14 PM

Post# of 2790
ITEM 8.01 OTHER EVENTS

On June 8, 2021, the United States Patent Office issued US Patent 11,028,155 to the Company. The patent is for Enhanced Delivery of Drugs to the Brain. This was the official issuance of the Patent.

The Phase 1 clinical trial has commenced enrollment of patients for the second cohort. People interested in more details concerning the trial may visit: https://www.clinicaltrials.gov/ct2/results?term=pritumumab&type=Intr&cond=Brain+Cancer&phase=0
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News